Caregiver Profile

Caregiver Profile

Meet Dr. Christine Mrakotsky


Undergraduate Degree

  • University of Vienna , 1992 , Vienna , Austria

Graduate Degree

  • University of Vienna , 1996 , Vienna , Austria


  • University of Minnesota Medical School , 1997 , Minneapolis , MN


Clinical Psychology
  • University of Vienna/Washington University , 2001 , Vienna, Austria/St. Louis , MO


  • Medical University of Vienna , 1998 , Vienna , Austria


Pediatric Neuropsychology
  • Boston Children's Hospital , 2003 , Boston , MA


Dr. Mrakotsky is a pediatric neuropsychologist and clinical investigator at Boston Children’s Hospital, and Assistant Professor of Psychology at Harvard Medical School. Her clinical and research work focuses on brain and cognitive development in pediatric stroke and inflammatory bowel disease.  She received her PhD in Clinical Psychology from the University of Vienna in collaboration with Washington University in St. Louis.  She completed a two-year postdoctoral fellowship in pediatric neuropsychology at Boston Children's Hospital, followed by research training and career development awards from Children’s Hospital and NIH. Dr. Mrakotsky is the recipient of the NIH Mitchell Max Award for Research Excellence and Harvard Medical School Shore Scholar. She is a licensed psychologist and health service provider in both Massachusetts and Austria.

Dr. Mrakotsky joined the Children’s Hospital faculty in 2003. Since 2013 she is the lead neuropsychologist for the Cerebrovascular Disorders and Stroke Program, Department of Neurology, establishing a new inpatient and outpatient neuropsychological service for pediatric stroke. Her research focuses on the neuropsychological outcomes of stroke, neurobehavioral effects of steroid therapy, as well as brain and neuropsychological function in pediatric IBD. With foundation and NIH grants, her lab employs advanced neuroimaging, neuropsychological assessment, and biomarker assays to study brain-immune interactions in IBD.


Publications powered by Harvard Catalyst Profiles

  1. Adverse effects of erenumab on cerebral proliferative angiopathy: A case report. Cephalalgia. 2021 01; 41(1):122-126. View abstract
  2. Functional abdominal pain symptom severity: Associations between cognition and emotion in a pediatric sample. Appl Neuropsychol Child. 2020 Jun 13; 1-12. View abstract
  3. Prevalence of Symptoms of Anxiety, Depression, and Post-traumatic Stress Disorder in Parents and Children Following Pediatric Stroke. J Child Neurol. 2020 06; 35(7):472-479. View abstract
  4. Neuropsychological function in children with hemophilia: A review of the Hemophilia Growth and Development Study and introduction of the current eTHINK study. Pediatr Blood Cancer. 2020 01; 67(1):e28004. View abstract
  5. O-003 The Brain as Extraintestinal IBD Manifestation: Are Brain and Cognitive Differences in Pediatric Crohn's Disease Associated with Immune Gene Expression? Inflamm Bowel Dis. 2017 Feb; 23 Suppl 1:S1-S2. View abstract
  6. O-018 New Evidence for Structural Brain Differences in Pediatric Crohn's Disease: Impact of Underlying Disease Factors. Inflamm Bowel Dis. 2016 Mar; 22 Suppl 1:S6-7. View abstract
  7. Pediatric inflammatory bowel disease and depression: treatment implications. Curr Opin Pediatr. 2014 Oct; 26(5):561-7. View abstract
  8. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav. 2014 Jul; 36:102-7. View abstract
  9. Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014 May; 58(5):574-81. View abstract
  10. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013 Jan; 19(1):96-109. View abstract
  11. Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor. Compr Psychiatry. 2012 Nov; 53(8):1194-9. View abstract
  12. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Pediatr Blood Cancer. 2011 Sep; 57(3):492-8. View abstract
  13. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010 Jul; 18(3):229-37. View abstract
  14. The Effects of Corticosteroids and Inflammation on Memory in Pediatric Crohn’s Disease: A Longitudinal Pilot Study. Central Society fo Clinical Research/Midwestern Section American Federation for Medical Research Combined 2009 Meeting. 2009. View abstract
  15. Corticosteroids, Immune Factors and Memory in Pediatric Chronic Illness: First Results on the Long-Term Effects of Steroids. International Neuropsychological Society, Abstract Handbook. 2009. View abstract
  16. Risperidone in Preschool Children with Autistic Spectrum Disorders. Advances in Preschool Psychopharmacology (Eds: JL Luby, MA Riddle). 2009; 87-99. View abstract
  17. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. J Psychiatr Pract. 2008 May; 14(3):160-9. View abstract
  18. The NIH MRI study of normal brain development: performance of a population based sample of healthy children aged 6 to 18 years on a neuropsychological battery. J Int Neuropsychol Soc. 2007; 13(5):729-46. PMID: 17511896. View abstract
  19. Psychiatric disorders and behavioral characteristics of pediatric patients with epilepsy and ADHD. Journal of Epilepsy and Behavior. 2007; 10(3):384-8. PMID: 17368109. View abstract
  20. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav. 2007 May; 10(3):384-8. View abstract
  21. Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord. 2008; 22(1):88-97. View abstract
  22. Concepts of developmental neuropsychology (Konzepte der Entwicklungsneuro-psychologie). Kaufmann L, Nürk HC, Konrad K, Willmes K. Kognitive Entwicklungsneuropsychologie. 2007; 25-44. View abstract
  23. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):575-87. View abstract
  24. Behavioral and Emotional Functioning in Patients with Epilepsy Treated with Vagal Nerve Stimulator: A Naturalistic Follow-Up Study[abstract]. International Neuropsychological Society, Astract Handbook. 2006. View abstract
  25. Neuropsychological assessment. Luby JL, editor. Handbook of Preschool Mental Health. 2006; 283-310. View abstract
  26. The NIH MRI study of normal brain development. Neuroimage. 2006; 30(1):184-202. PMID: 16376577.. View abstract
  27. Chemotherapy agents for treatment of acute lymphoblastic leukemia. Bellinger D, editor. Human Developmental Neurotoxicology. 2006; 131-147. View abstract
  28. Cognitive development. Luby JL, editor. Handbook of Preschool Mental Health. 2006; 45-60. View abstract
  29. Practiced intelligence testing based on a modern test conceptualization and its reference to the common intelligence theories. Learning and Individual Differences. 2006; 16:175-193. View abstract
  30. Entwicklungsneuropsychologie (Developmental neuropsychology). Lerner H, Pusswald G, Kryspin-Exner I, editors. Lehrbuch der Klinischen Neuropsychologie. 2006; 373-384. View abstract
  31. Executive functions and memory in children treated for inflammatory bowel disease: Impact of steroids vs. disease factors [abstract]. International Neuropsychological Society, Abstract Handbook. 2006. View abstract
  32. Impact of acute steroid treatment on memory, executive function, and mood in pediatric inflammatory bowel disease [abstract]. Journal of Pediatric Gastroenterology & Nutrition. 2005; 41(4):540-541.. View abstract
  33. Characteristics of depressed preschoolers with and without anhedonia: evidence for a melancholic depressive subtype in young children. Am J Psychiatry. 2004 Nov; 161(11):1998-2004. View abstract
  34. Neurobehavioral side effects of steroid treatment in children with leukemia [abstract]. Journal of the International Neuropsychological Society. 2004; 10(2). View abstract
  35. Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry. 2003 Dec; 60(12):1248-55. View abstract
  36. Modification of DSM-IV criteria for depressed preschool children. Am J Psychiatry. 2003 Jun; 160(6):1169-72. View abstract
  37. The clinical picture of depression in preschool children. J Am Acad Child Adolesc Psychiatry. 2003 Mar; 42(3):340-8. View abstract
  38. Depressed preschoolers with bipolar family history: a group at high risk for later switching to mania? J Child Adolesc Psychopharmacol. 2003; 13(2):187-97. View abstract
  39. Preschool major depressive disorder: preliminary validation for developmentally modified DSM-IV criteria. J Am Acad Child Adolesc Psychiatry. 2002 Aug; 41(8):928-37. View abstract
  40. Spatial cognition, face perception, and affect recognition in preschool depressive syndromes. A neuropsychological framework of social information processing [doctoral dissertation]. 2001. View abstract
  41. Intelligenzdiagnostikum fuer das Vorschulalter: Entwicklung einer Testbatterie fuer 5jaehrige als Ergaenzung zum AID. (Intelligence scale for the preschool age: Development of a cognitive battery as supplement to the AID scale)[Master's Thesis]. 1996. View abstract